VIDEO: Acorda Therapeutics, Inc. (ACOR)

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), a potassium channel blocker to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and Zanaflex tablets for the management of spasticity, a symptom of central nervous system disorders; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia.

The company also markets Ampyra as Fampyra in Europe, Asia, and the Americas. It is also involved in developing CVT-301, which is in Phase III clinical trial for the treatment of OFF episodes in ParkinsonÂ’s disease; Dalfampridine that is in Phase III clinical trial for the treatment of chronic post-stroke deficits; Neuregulin Program, which is in Phase Ib clinical trial for the treatment of heart failure; CVT-427 that is in pre-clinical development for the treatment of migraines; Remyelinating Antibodies Program, which is in Phase I clinical trial for the treatment of MS; and Chondroitinase Program that is in research stage for the treatment of spinal cord injury, as well as developing Plumiaz, a proprietary nasal spray formulation of diazepam for the treatment of people with epilepsy. The company has a collaboration agreement with Biogen Idec International GmbH for the development and commercialization of products containing aminopyridines. The company was founded in 1995 and is headquartered in Ardsley, New York.


Get the Latest Videos

Small Cap Movers


PNK : DPWW - 11 Aug, 1:21pm
+0.04 (+5.88%) After Hours:
Open 0.51 Mktcap 27.22M
High 0.72 52wk Hight 0.72
Low 0.51 52wk Low 0.51
Vol 24535 Avg Vol
Eps P/e
Currency: USD


PNK : BKYI - 11 Aug, 3:59pm
+0.00 (+0.00%) After Hours:
Open 0.24 Mktcap 15.92M
High 0.24 52wk Hight 0.31
Low 0.24 52wk Low 0.10
Vol 43614 Avg Vol 132241
Eps P/e
Currency: USD

Chanticleer Holdings, Inc.

NCM : HOTR - 11 Aug, 3:58pm
-0.03 (-6.25%) After Hours:
Open 0.49 Mktcap 9.60M
High 0.49 52wk Hight 1.72
Low 0.42 52wk Low 0.40
Vol 80302 Avg Vol 81369
Eps -0.27 P/e
Currency: USD

NanoViricides, Inc. NEW Common

ASE : NNVC - 11 Aug, 4:00pm
+0.02 (+1.20%) After Hours:
Open 1.69 Mktcap 97.97M
High 1.71 52wk Hight 3.44
Low 1.68 52wk Low 0.89
Vol 57749 Avg Vol 122053
Eps -0.20 P/e
Currency: USD

Sign Up For Our Newsletter